Log on / register
Feedback | Support | My details
An overview of harms associated with beta-lactam antimicrobials: where do the carbapenems fit in?
Owens RC
Crit Care 2008, 12 Suppl 4:S3
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
38%38%


 Introduction
Optimizing the use of carbapenems in the face of increasing Gram-negative resistance
Ramphal R
Critical Care 2008, 12(Suppl 4):S1 (21 May 2008)
[Full text] [PubMed Central] [PubMed] [Related articles]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.